(9ci)-1-(甲氧基甲基)-1H-苯并咪唑 | 18249-98-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 中文名称: (9ci)-1-(甲氧基甲基)-1H-苯并咪唑
• 英文名称: 1-(methoxymethyl)-1H-benzo[d]imidazole
• 英文别名: 1-methoxymethylbenzimidazole；1-(Methoxymethyl)benzoimidazole；1-(methoxymethyl)benzimidazole
• CAS: 18249-98-4
• 化学式: C₉H₁₀N₂O
• mdl: MFCD00956939
• 分子量: 162.191
• InChiKey: IGVBEHIUIDPEKE-UHFFFAOYSA-N

物化性质

• 沸点：
  147-148 °C(Press: 3 Torr)
• 密度：
  1.14±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  27
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-(Methoxymethyl)benzoimidazole
Synonyms: 1-(Methoxymethyl)-1H-benzo[d]imidazole

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-(Methoxymethyl)benzoimidazole
CAS number: 18249-98-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H10N2O
Molecular weight: 162.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (9ci)-1-(甲氧基甲基)-1H-苯并咪唑 在 盐酸 、 正丁基锂 、 四丁基氟化铵 、 N,N'-二环己基碳二亚胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 44.0h， 生成 5-amino-4-hydroxy-6-phenylhexanoic acid ((1H-benzimidazol-2-yl)phenylmethyl)amide
  参考文献：
  名称：

  HIV蛋白酶的新型C末端抑制剂的基于晶体结构的设计和合成。

  摘要：

  描述了基于X射线晶体结构的设计，合成，计算评估和新型HIV蛋白酶抑制剂的活性。通过将已知羟基乙烯抑制剂的C端Val-Val-OCH3的取代基建模到已报道的与MVT-101结合的HIV蛋白酶晶体结构的活性位点中，来设计初始铅化合物2和3。发现铅化合物2是适度的抑制剂，Ki ＝1.67μM。解决了与HIV蛋白酶复合的化合物2的X射线晶体结构，并将其用于后续设计。发现前导化合物3是更有效的抑制剂，Ki = 0.2 microM，并且其与HIV蛋白酶复合的结构也被解析并用于后续设计。吲哚3的C-末端和N-末端的修饰均导致Ki ＝ 30nM的化合物。以HIV蛋白酶为起点的化合物2和3的晶体结构，将热力学循环扰动分子动力学方法应用于一组选定的化合物，以便在一系列密切相关的化合物中测试此类计算的准确性。

  DOI：

  10.1021/jm00041a005
• 作为产物：
  描述：

  苯并咪唑 、 氯甲基甲基醚 在 NaH 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 (9ci)-1-(甲氧基甲基)-1H-苯并咪唑
  参考文献：
  名称：

  Bicyclic compounds

  摘要：

  本发明涉及公式［I］的新的双环化合物及其药学上可接受的盐，其中R1、R2、R3、R4、R5、R6、R7、Q1、Q2和Q3如权利要求中所定义。这些化合物具有N-肉豆蔻酰基转移酶抑制和抗真菌活性。

  公开号：

  US06376491B1

文献信息

• HETEROBICYCLIC COMPOUNDS
  申请人：Amgen Inc.

  公开号：US20130225552A1

  公开（公告）日：2013-08-29

  Heterobicyclic compounds of Formula (I): or a pharmaceutically-acceptable salt, tautomer, or stereoisomer thereof, as defined in the specification, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, Huntington's Disease, and the like.

  Formula (I)的杂环化合物： 或其药用可接受的盐、互变异构体或立体异构体，如规范中所定义，并含有它们的组合物，以及制备这种化合物的方法。本文还提供了通过抑制PDE10来治疗由此可治疗的疾病或疾病的方法，如肥胖症、非胰岛素依赖型糖尿病、精神分裂症、躁郁症、强迫症、亨廷顿病等。
• C–H arylation and alkenylation of imidazoles by nickel catalysis: solvent-accelerated imidazole C–H activation
  作者：Kei Muto、Taito Hatakeyama、Junichiro Yamaguchi、Kenichiro Itami

  DOI：10.1039/c5sc02942b

  日期：——

  The first nickel-catalyzed C–H arylations and alkenylations of imidazoles with phenol and enol derivatives are described.

  第一个镍催化的咪唑与酚和烯醇衍生物的C-H芳基化和烯基化反应被描述了。
• Bicyclic compounds
  申请人：Basilea Pharmaceutica AG

  公开号：US06376491B1

  公开（公告）日：2002-04-23

  The present invention is directed to new bicyclic compounds of the formula [I], and pharmaceutically acceptable salts thereof wherein R1, R2, R3, R4, R5, R6, R7, Q1 Q2 and Q3 are as defined in the claims. The compounds have N-myristoyltransferase inhibitory and antifungal activity.

  本发明涉及公式［I］的新的双环化合物及其药学上可接受的盐，其中R1、R2、R3、R4、R5、R6、R7、Q1、Q2和Q3如权利要求中所定义。这些化合物具有N-肉豆蔻酰基转移酶抑制和抗真菌活性。
• A Facile and Efficient Procedure for the Synthesis of New Benzimidazole-2-thione Derivatives
  作者：Augusto Rivera、Mauricio Maldonado、Jaime Ríos-Motta

  DOI：10.3390/molecules17078578

  日期：——

  A series of benzimidazole-2-thione derivatives was synthesized using a reaction between the macrocyclic aminal 16H,13H-5:12,7:14-dimethanedibenzo[d,i]-[1,3,6,8] tetraazecine (DMDBTA, 5) and various nucleophiles in the presence of carbon disulfide. A full chemical characterization using IR, 1H-, 13C-NMR and GC-MS analyses of the new compounds is provided. These compounds were separated from the reaction mixture by column chromatography (CC) in highly pure form in 15%–51.4% yield.

  一系列苯并咪唑-2-硫酮衍生物通过使用碳二硫化物作为溶剂，宏观环状亚胺16H，13H-5:12，7:14-二甲烷二苯并[d,i]-[1,3,6,8]四氮杂环庚烷（DMDBTA，5）与各种亲核试剂的反应来合成。通过红外光谱、氢核磁共振、碳核磁共振和气相色谱质谱分析对新化合物进行了全面的化学表征。这些化合物以高达15%–51.4%的产率从反应混合物中通过柱色谱法分离出来，并以高度纯净的形式得到。
• Nano indium oxide-catalyzed domino reaction for the synthesis of N-alkoxylated benzimidazoles
  作者：Satyajit Samanta、Sachinta Mahato、Rana Chatterjee、Sougata Santra、Grigory V. Zyryanov、Adinath Majee

  DOI：10.1016/j.tetlet.2020.152177

  日期：2020.8

  cyclocondensation reaction of simple ortho-phenylenediamine, formaldehyde and alcohols in presence of indium oxide nanoparticles as catalyst. The alcohol acts as reactant as well as solvent in this reaction. No other solvents or additives have been used for this reaction. The catalyst can be reused several times without significant loss of catalytic activity. A probable reaction mechanism has been

  已经开发了一种方便的方法，用于在氧化铟纳米粒子作为催化剂的情况下，通过简单的邻苯二胺，甲醛和醇类的环缩合反应选择性合成N-烷氧基化的苯并咪唑衍生物。醇在该反应中既充当反应物又充当溶剂。没有其他溶剂或添加剂已用于该反应。催化剂可以重复使用几次，而不会明显降低催化活性。基于一些控制实验，提出了一种可能的反应机理。